COMPARATIVE STUDY OF ANTI-INFLAMMATORY ACTIVITY OF AQUEOUS AND METHANOLIC EXTRACTS OF HIBISCUS CANNABINUS LEAF (MALVACEAE)
Objective: The present study was undertaken to investigate and compare the anti-inflammatory activity of an aqueous and methanolic extract of Hibiscus cannabinus (Malvaceae) using carrageenan-induced rat paw edema.
Methods: Aqueous and methanolic extracts of Hibiscus cannabinus was prepared and tested for anti-inflammatory activity in female spargue dawley rat weighing 150-180 g. The animals were randomly divided into 6 groups of 6 each. First group served as vehicle control, second group served as standard, third and fourth group served as high (400 mg/kg) and low (200 mg/kg) dose of methanolic extract of Hibiscus cannabinus leaves (MHCL) respectively and fifth and sixth group as high (400 mg/kg) and low (200 mg/kg) dose of aqueous extract of Hibiscus cannabinus leaves (AHCL) respectively. The In vivo anti-inflammatory activity was studied using carrageenan induce rat paw edema animal model. The estimation of liver and blood parameters consist of serum glutamic oxalate transaminase (SGOT), serum glutamic pyruvate transaminase (SGPT), lipid peroxidation (LPO), reduced glutathione (GSH) and superoxide dismutase (SOD).
Results: Both MHCL and AHCL extracts showed significant (*p<0.05) inhibition of rat paw edema in dose-dependent manner. The maximum percent inhibition in paw edema was found in MHCL at dose of 400 mg/kg was 52.00% and AHCL at dose of 400 mg/kg was 49.93%. Both MHCL and AHCL at dose of 400 mg/kg reduce LPO level as 31.10 nmol/g and 35.23 nmol/g respectively when compared with standard indomethacin.
Conclusion: An anti-inflammatory activity was found in both MHCL and AHCL extracts. But the MHCL showed more significant anti-inflammatory activity.Keywords: Hibiscus cannabinus, Anti-inflammatory, Carrageenan, Indomethacin, Edema
Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-BD, Croxtall, et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-50.
Pakrashi SC. Herbal drugs, nutraceuticals and rural health. Tenth Asian symposium on medicinal plants, species, and other natural products. Dhaka Bangladesh; 2000. p. 63.
Shamsuddin Ahmad, Van der Vossen. H. A. M. Hibiscus cannabinus L. Plant Resources of South-East Asia No 17. Fibre plants. Backhuys Publishers. Leiden Netherlands; 2003. p. 156â€“62.
Gabriel AA, Julius EO, Jeanne YN. The haematinic activity of Hibiscus Cannabinus. Afr J Biotechnol 2005;4:833-7.
Mozaina K, Mario RT, Charles LW, Franck ED, Kevin KS, David EW. Phytotoxic and fungitoxicity activities of the essential oil of kenaf (Hibiscus cannabinus L.) Leaves and Its composition. J Agric Food Chem 2001;49:3768â€“71.
Prosper-Cabral NB, Gabriel AA, Jeanne YN. Phytochemical studies and antioxidant properties of four medicinal plants used in cameroon. Afr J Tradit Complementary Altern Med 2007;4:495-500.
Yong GL, Byeon SE, Kim JY, Ji Yeon, Rhee MH, Hong S, et al. Immunomodulatory effect of Hibiscus cannabinus extract on macrophages function. J Ethnopharmacol 2007;113:62-71.
Sundarrajan T, Raj Kumar T, Udhayakumar E, Sekar M, Senthil Kumar MK. Anti-diabetic activity of methanolic extract of Hibiscus cannabinus in streptozotocin-induced diabetic rat. Int J Pharma Bio Sci 2011;1:125-30.
Shivali, Mahadevan N, Pradeep K. Antihyperlipidemic effect of hydroalcoholic extract of Kenaf (Hibiscus cannabinus L.) leaves in high-fat diet fed rats. Ann Biol Res 2010;1:174-81.
Winter CA, Risley E, Nuss G. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962;111:544-7.
Reitman S, Frankel S. A colorimetric method for the determination of SGPT and SGOT. Am J Clin Pathol 1957;28:56-62.
Singh S, Majumdar DK. Ocimum sanctum-phytochemical and pharmacological evaluation. Recent Prog Med Plants 1998;2:1-81.
Turner, Robert, Hebborn P. Screening methods in pharmacology. (Volume I). Published by an academic press. INC. New York; 1971. p. 23-65.
Chatpalliwar VA, Joharapurkar AA, Wanjari MM, Chakraborty RR, Kharkar VT. Anti-inflammatory activity of Martynia diandra Glox. Indian Drugs 2002;39:543-5.
Somud AM, Asmawi MZ, Sharma JN, Yusuf APM. Anti-inflammatory activity of crinum asiaticum plant and its effect on bradykinin-induced contraction on the isolated uterus. Immunopharmacology 1999;43:311-6.
Rosa MD, Sorrentino L. The mechanism of the inflammatory effect of carrageenan. Eur J Pharmacol 1968;4:340-2.
Bhatt KGS, Sanyal RK. Association of histamine and 5-Hydroxytryptamine with the inflammatory process. J Pharm Pharmacol 1962;15:78-9.
Kuels FA, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science 1980;210:978-84.
Vinegar R, Schreiber W, Hugo R. Biphasic development of carrageenan edema in rats. J Pharmacol Exp Ther 1969;166:95-103.
Debs AC. Fundamentals of biochemistry. New central book agency (p) Ltd; 1998. p. 325-58.
Mohan H. Ed. In: Textbook of Pathology. 4th Eds. Jaypee Brothers, Medical Publishers (P) Ltd New Delhi; 2000. p. 114-9.
Sharma SK, Murti CRK. The action of rutin antioxidants and metabolic inhibitors on lipid peroxide formation in rat tissues. Indian J Exp Biol 1963;1:5-11.
Khanam S, Shivprasad HN, Devi K. In-vitro antioxidant screening models: a review. Indian J Pharm Education 2004;38:180-3.
Blake DR, Allen RE, Lunee J. Free radicals in biological systems-a review orientated to inflammatory processes. Br Med Bull 1987;43:371-85.
Sharma SC, Mukthar H, Sharma SK, Krishna CR. Lipid peroxides formation in experimental inflammation. Biochem Pharmacol 1972;21:1210-4.
Wills ED, Wilkson AE. The release of the enzyme from lysosomes by irradiation and the relation of lipid peroxide formation to enzyme release. Biochem J 1969;99:657-66.